Bibby Scientific, one of the largest manufacturers of quality bench top science equipment, has purchased 100% of the share capital of PCRmax, a UK based sales and distribution Company set up specifically to capture a significant market share of the standard (PCR) and quantitative PCR (QPCR) markets.
They are also the registered owners of the intellectual property previously owned by Illimina Inc with respect to the ECO QPCR instrument.
PCRmax will launch the innovative ECO 48 well QPCR platform which has market leading uniformity and ramp rates allowing a real time experiment to be completed in as little as 8 minutes. A wide range of QPCR research kits and consumables will further enhance the product offering at launch. Over the next 12 months a further 3 instruments in the PCR and QPCR range plus supporting life science products will be added to this innovative offering.
Commenting on the acquisition, Dr James Heffernan, CEO of Bibby said, “This acquisition underlines our determination to become a leading global player in the life science equipment arena through the offer of technologically leading products at prices affordable by scientists worldwide. The addition of a comprehensive range of quality research kits for use on the new platforms should prove a compelling offering to our customers”.
About Bibby Scientific
One of four new companies established by Nova Capital from the former Barloworld Scientific business, acquired in November 2007, Bibby Scientific Limited focuses on the design, manufacture and distribution of four world-leading benchtop laboratory equipment brands: Jenway®, Stuart®, Techne® and Electrothermal®.
The 2011 acquisition of Electrothermal®, market leaders in heating mantle design and manufacture, adds an extensive range of outstanding products which complement Bibby Scientific’s broad-based portfolio.
All four brands are available through good laboratory distributors worldwide. Bibby Scientific Ltd has subsidiaries in the USA, France and Singapore, as well as an associated company in the Middle East.